Boston Scientific to Participate in Wells Fargo's 2024 Healthcare Conference
Boston Scientific (NYSE: BSX) has announced its participation in Wells Fargo's 2024 Healthcare Conference on September 4, 2024. The company's chairman and CEO, Mike Mahoney, along with Dr. Brad Sutton, chief medical officer of Atrial Fibrillation Solutions, will engage in a 35-minute Q&A session with the host analyst, starting at approximately 8:00 a.m. ET.
Investors and interested parties can access a live webcast of the session through the Boston Scientific investor relations website. A replay of the event will be made available about an hour after its conclusion, providing an opportunity for those unable to attend the live session to catch up on the discussion.
Boston Scientific (NYSE: BSX) ha annunciato la sua partecipazione alla Wells Fargo Healthcare Conference 2024 che si terrà il 4 settembre 2024. Il presidente e CEO dell'azienda, Mike Mahoney, insieme a Dr. Brad Sutton, direttore medico delle Soluzioni per la Fibrillazione Ateriale, parteciperà a una sessione di domande e risposte di 35 minuti con l'analista ospitante, che avrà inizio intorno alle 8:00 a.m. ET.
Gli investitori e le parti interessate possono accedere a un webcast live della sessione tramite il sito web delle relazioni con gli investitori di Boston Scientific. Una registrazione dell'evento sarà disponibile circa un'ora dopo la sua conclusione, offrendo l'opportunità a coloro che non possono partecipare alla sessione dal vivo di recuperare la discussione.
Boston Scientific (NYSE: BSX) ha anunciado su participación en la Wells Fargo Healthcare Conference 2024 que se llevará a cabo el 4 de septiembre de 2024. El presidente y CEO de la compañía, Mike Mahoney, junto con el Dr. Brad Sutton, director médico de Soluciones de Fibrilación Auricular, participará en una sesión de preguntas y respuestas de 35 minutos con el analista anfitrión, comenzando aproximadamente a las 8:00 a.m. ET.
Los inversores y partes interesadas pueden acceder a un webcast en vivo de la sesión a través del sitio web de relaciones con inversores de Boston Scientific. Una repetición del evento estará disponible aproximadamente una hora después de su conclusión, lo que brinda la oportunidad a aquellos que no puedan asistir a la sesión en vivo de ponerse al día con la discusión.
바이오젠(Boston Scientific) (NYSE: BSX)이 웰스 파고 2024 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 이 컨퍼런스는 2024년 9월 4일에 열릴 예정입니다. 회사의 회장 겸 CEO인 마이크 마호니(Mike Mahoney)는 브래드 서튼 박사(Dr. Brad Sutton)와 함께 심방세동 솔루션의 최고 의료 책임자로서 35분 질문 및 답변 세션에 참여하며, 약 오전 8시(ET)에 시작됩니다.
투자자 및 관심 있는 분들은 보스턴 사이언티픽 투자자 관계 웹사이트를 통해 해당 세션의 실시간 웹캐스트에 접속할 수 있습니다. 세션 종료 약 한 시간 후에는 재방송이 제공되어, 실시간 세션에 참석할 수 없는 분들이 토론을 따라잡을 수 있는 기회를 제공합니다.
Boston Scientific (NYSE: BSX) a annoncé sa participation à la Wells Fargo Healthcare Conference 2024 qui se tiendra le 4 septembre 2024. Le président et CEO de l'entreprise, Mike Mahoney, et Dr. Brad Sutton, directeur médical des Solutions de Fibrillation Auriculaire, participeront à une session de questions-réponses de 35 minutes avec l'analyste hôte, débutant à environ 8h00 ET.
Les investisseurs et les parties intéressées peuvent accéder à un webcast en direct de la session via le site web des relations investisseurs de Boston Scientific. Une rediffusion de l'événement sera disponible environ une heure après sa conclusion, offrant ainsi une opportunité à ceux qui ne peuvent pas assister à la session en direct de rattraper la discussion.
Boston Scientific (NYSE: BSX) hat seine Teilnahme an der Wells Fargo Healthcare Conference 2024 am 4. September 2024 bekannt gegeben. Der Vorsitzende und CEO des Unternehmens, Mike Mahoney, wird gemeinsam mit Dr. Brad Sutton, dem Chief Medical Officer von Atrial Fibrillation Solutions, an einer 35-minütigen Frage-und-Antwort-Sitzung mit dem Gastgeber-Analysten teilnehmen, die ungefähr um 8:00 Uhr ET beginnt.
Investoren und interessierte Parteien können über die Investor-Relations-Website von Boston Scientific auf einen Live-Webcast der Sitzung zugreifen. Eine Wiederholung der Veranstaltung wird etwa eine Stunde nach Abschluss zur Verfügung stehen, sodass diejenigen, die nicht an der Live-Sitzung teilnehmen können, die Diskussion nachholen können.
- None.
- None.
Mike Mahoney, chairman and chief executive officer, and Dr. Brad
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Jon Monson
Investor Relations
+1 (508) 683-5450
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-wells-fargos-2024-healthcare-conference-302219961.html
SOURCE Boston Scientific Corporation
FAQ
When is Boston Scientific (BSX) participating in Wells Fargo's 2024 Healthcare Conference?
Who will represent Boston Scientific (BSX) at the Wells Fargo Healthcare Conference?
What format will Boston Scientific's (BSX) presentation take at the Wells Fargo conference?
At what time does Boston Scientific's (BSX) Q&A session start at the Wells Fargo conference?
How can investors access Boston Scientific's (BSX) presentation at the Wells Fargo conference?
